Neurologic Complications in Treated HIV-1 Infection

被引:19
|
作者
Bhatia, Nisha S. [1 ]
Chow, Felicia C. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA
关键词
Neurological complications; HIV infection; Viral suppression; CENTRAL-NERVOUS-SYSTEM; COMBINATION ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; PLACEBO-CONTROLLED TRIAL; POPULATION-BASED COHORT; C VIRUS COINFECTION; NEUROCOGNITIVE IMPAIRMENT; PERIPHERAL NEUROPATHY; CARDIOVASCULAR-DISEASE; NEUROPSYCHOLOGICAL IMPAIRMENT;
D O I
10.1007/s11910-016-0666-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Effective combination antiretroviral therapy has transformed HIV infection into a chronic disease, with HIV-infected individuals living longer and reaching older age. Neurological disease remains common in treated HIV, however, due in part to ongoing inflammation and immune activation that persist in chronic infection. In this review, we highlight recent developments in our understanding of several clinically relevant neurologic complications that can occur in HIV infection despite treatment, including HIV-associated neurocognitive disorders, symptomatic CSF escape, cerebrovascular disease, and peripheral neuropathy.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] HIV-1 infection and neurocognitive impairment in the current era
    del Palacio, Maria
    Alvarez, Susana
    Munoz-Fernandez, M. Angeles
    REVIEWS IN MEDICAL VIROLOGY, 2012, 22 (01) : 33 - 45
  • [42] SENTINEL SURVEILLANCE OF HIV-1 INFECTION IN TAMILNADU, INDIA
    SOLOMON, S
    ANURADHA, S
    GANAPATHY, M
    JAGADEESWARI
    INTERNATIONAL JOURNAL OF STD & AIDS, 1994, 5 (06) : 445 - 446
  • [43] Elucidating the elite: mechanisms of control in HIV-1 infection
    O'Connell, Karen A.
    Bailey, Justin R.
    Blankson, Joel N.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (12) : 631 - 637
  • [44] Development of acute psychotic disorders and HIV-1 infection
    De Ronchi, D
    Faranca, I
    Forti, P
    Ravaglia, G
    Borderi, M
    Manfredi, R
    Volterra, V
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2000, 30 (02) : 173 - 183
  • [45] Dolutegravir plus lamivudine for the treatment of HIV-1 infection
    Ciccullo, Arturo
    Baldin, Gianmaria
    Borghetti, Alberto
    Di Giambenedetto, Simona
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (04) : 279 - 292
  • [46] Neuropathogenesis of HIV-1 infection. Outstanding questions
    Vitkovic, L
    Tardieu, M
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1998, 321 (12): : 1015 - 1021
  • [47] Insulin resistance in treated HIV infection
    Feeney, E. R.
    Mallon, P. W. G.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 25 (03) : 443 - 458
  • [48] HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies
    Gorry, Paul R.
    Francella, Nicholas
    Lewin, Sharon R.
    Collman, Ronald G.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 95 (01) : 71 - 81
  • [49] Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection
    Killingsworth, Lauren
    Spudich, Serena
    SEMINARS IN IMMUNOPATHOLOGY, 2022, 44 (05) : 709 - 724
  • [50] Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection
    Lauren Killingsworth
    Serena Spudich
    Seminars in Immunopathology, 2022, 44 : 709 - 724